Specialist Oversight for Global Rare Disease Research
UK Hospitals
Hospital Staff Relationships
Years of Experience
While we manage a broad clinical portfolio, we have developed a dedicated proficiency in the high-stakes environment of orphan drugs and rare conditions. Operating as a global CRO with UK headquarters, our team provides both targeted phase-specific support and comprehensive end-to-end management. We partner with biotechnology innovators and academic specialists to deliver trials that are scientifically rigorous, operationally realistic, and deeply sensitive to the unique journeys of patients living with rare diseases.
Navigating the Nuances of Rare Disease Trials
Clinical research in rare diseases presents challenges that standard trial frameworks simply cannot meet.
In this field, the mantra is that every patient is precious, and every data point is invaluable.
While high-quality data is the goal of any study, in rare disease research, a single missed measurement or one lost participant can significantly impact the statistical power of the entire programme.
We design frameworks that balance the need for robust data with the practicalities of patient burden, ensuring that study visits and procedures are as accessible as possible for families and caregivers.
The Complexity of Hub-and-Spoke Coordination
Finding the right sites for a rare disease trial requires more than just a list of hospitals; it requires deep local intelligence.
Through our experience with UK and European sites, we understand the intricate "hub-and-spoke" relationship between local clinics and specialist Centres of Excellence.
Successfully funnelling patients from smaller, local sites to central primary hubs is an operationally tricky task.
It requires seamless coordination between different medical teams, complex referral pathways, and synchronised data sharing. Our advantage comes from years of direct, on-the-ground collaboration with these networks.
We act as the glue in this process, managing the tricky logistics of patient movement and site-to-site communication to ensure that no patient is missed and that their transition into the study environment is smooth and safe.
Global Coordination for Niche Populations
The success of rare disease trials hinges on the ability to coordinate across borders, ensuring a seamless patient journey whether that means crossing international lines or navigating different regional health systems.
We specialise in managing the high-intensity requirements of these studies, including bespoke patient travel logistics, home-nursing integration, and the synchronisation of complex laboratory samples across international sites.
We act as the vital link between the sponsor, the clinical sites, and the patient community, ensuring that data is captured with the mathematical precision required for regulatory submissions, even when the patient numbers are small.
Frequently Asked Questions
What range of services do you provide for rare disease trials?
We offer a full-service model including protocol design, orphan drug designation support, regulatory submissions, and global site management. We also provide specialist support for patient recruitment and retention strategies tailored to niche populations.
How do you help sponsors manage the funnel from local sites to centres?
Because we know the UK and Western European sites so intimately, we help establish the referral pathways needed to bring patients from regional hospitals to central hubs. We handle the tricky coordination required to ensure that the patient's journey and data flow are maintained throughout the process.
Can you handle the regulatory hurdles for orphan drugs?
Yes. Our team is well-versed in the specific regulatory pathways for rare diseases, including the requirements for small sample sizes and natural history studies. We manage complex submissions to the MHRA, EMA, and other global bodies, ensuring all safety reporting meets international standards.
How do you ensure data integrity in small patient cohorts?
We treat every data point as precious. Our monitoring and data management processes are intensified for rare diseases to ensure that every measurement is captured accurately. We provide the high-level oversight needed to prevent data loss in these statistically sensitive studies.
What makes your project teams different from a large, generic CRO?
Continuity and empathy. In rare disease research, you won't deal with a revolving door of staff. Our senior experts stay with your project from the initial feasibility through to final reporting, fostering deep relationships with the specialist sites and understanding the clinical nuances of the condition.
Do you support companies with natural history and registry studies?
Absolutely. We have extensive experience in designing and managing the longitudinal studies that often underpin rare disease drug development. We provide the framework needed to capture real-world data and build the evidence base required for future interventional trials.
Case Study: Revitalising Enrolment for a Rare ITP Study
As the full-service partner for an open-label, dose-escalation study in adult patients with Immune Thrombocytopenia (ITP), we were brought in to rescue a programme that had hit a standstill.
Following a rigorous investigation into why sites were struggling to find patients, we implemented a practical recovery plan that focused on the clinical reality of the units.
We worked closely with the sponsor to simplify the inclusion criteria, removing unnecessary barriers that made the protocol difficult to execute in a real-world setting.
A major part of our success involved direct engagement with the nursing staff, who are the frontline of any rare disease study.
By providing evidence-based re-assurance regarding the drug’s tolerability and safety profile, we addressed their concerns and rebuilt the confidence needed to screen and enrol participants.
This hands-on approach revitalised the funnel from regional sites to central hubs, ensuring that every precious patient was captured and the study successfully met its global milestones.